Abstract | PURPOSE: METHODS: This was a noncomparative, nonrandomized, consecutive case series. All eyes with ocular toxoplasmosis-associated CNV received one intravitreal bevacizumab injection under the coverage of oral trimethoprim/sulfamethoxazole. The changes in best-corrected visual acuity were recorded. Serial fundus photography, fluorescein angiography, optical coherence tomography, and indocyanine green angiography were performed to measure the treatment efficacy. RESULTS: Three eyes of two patients with a history of ocular toxoplasmosis had active CNV demonstrated by fluorescein angiography and optical coherence tomography. Each was treated with oral trimethoprim/sulfamethoxazole and one intravitreal bevacizumab injection. Best-corrected visual acuity, fundus photographs, fluorescein angiography, optical coherence tomography, and indocyanine green angiography all showed favorable results. No ocular or systemic complications were noted. In all three eyes, the CNV subsided and vision improved. CONCLUSION:
|
Authors | Chun-Ju Lin, San-Ni Chen, Jiunn-Feng Hwang, Pei-Shin Hu |
Journal | Retinal cases & brief reports
(Retin Cases Brief Rep)
Vol. 5
Issue 4
Pg. 348-51
( 2011)
ISSN: 1935-1089 [Print] United States |
PMID | 25390432
(Publication Type: Journal Article)
|